BioForce Nanosciences Total Debt vs. Price To Book
| BFNH Stock | USD 0.60 0.00 0.00% |
For BioForce Nanosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioForce Nanosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioForce Nanosciences Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioForce Nanosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioForce Nanosciences Holdings over time as well as its relative position and ranking within its peers.
BioForce |
BioForce Nanosciences Price To Book vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioForce Nanosciences's current stock value. Our valuation model uses many indicators to compare BioForce Nanosciences value to that of its competitors to determine the firm's financial worth. BioForce Nanosciences Holdings is rated below average in total debt category among its peers. It is number one stock in price to book category among its peers fabricating about 0.01 of Price To Book per Total Debt. The ratio of Total Debt to Price To Book for BioForce Nanosciences Holdings is roughly 181.09 . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioForce Nanosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioForce Nanosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BioForce Total Debt vs. Competition
BioForce Nanosciences Holdings is rated below average in total debt category among its peers. Total debt of Packaged Foods industry is currently estimated at about 3.05 Billion. BioForce Nanosciences adds roughly 156,870 in total debt claiming only tiny portion of equities listed under Packaged Foods industry.
BioForce Price To Book vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
BioForce Nanosciences |
| = | 156.87 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
BioForce Nanosciences |
| = | 866.24 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
BioForce Price To Book Comparison
BioForce Nanosciences is currently under evaluation in price to book category among its peers.
BioForce Nanosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioForce Nanosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioForce Nanosciences will eventually generate negative long term returns. The profitability progress is the general direction of BioForce Nanosciences' change in net profit over the period of time. It can combine multiple indicators of BioForce Nanosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. BIOFORCE NANOSCIENCES operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 2 people.
BioForce Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioForce Nanosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioForce Nanosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioForce Nanosciences' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in BioForce Nanosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Use Investing Themes to Complement your BioForce Nanosciences position
In addition to having BioForce Nanosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Materials ETFs Thematic Idea Now
Materials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BioForce Pink Sheet
To fully project BioForce Nanosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BioForce Nanosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BioForce Nanosciences' income statement, its balance sheet, and the statement of cash flows.